Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles

Jeong Yeon Kim, Ju Hee Ryu, Dawid Schellingerhout, In Cheol Sun, Su Kyoung Lee, Sangmin Jeon, Jiwon Kim, Ick Chan Kwon, Matthias Nahrendorf, Cheol Hee Ahn, Kwang Meyung Kim, Dong Eog Kim

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Computed tomography (CT) is the current standard for time-critical decision-making in stroke patients, informing decisions on thrombolytic therapy with tissue plasminogen activator (tPA), which has a narrow therapeutic index. We aimed to develop a CT-based method to directly visualize cerebrovascular thrombi and guide thrombolytic therapy. Glycol-chitosan-coated gold nanoparticles (GC-AuNPs) were synthesized and conjugated to fibrin-targeting peptides, forming fib-GC-AuNP. This targeted imaging agent and non-targeted control agent were characterized in vitro and in vivo in C57Bl/6 mice (n = 107) with FeCl3-induced carotid thrombosis and/or embolic ischemic stroke. Fibrin-binding capacity was superior with fib-GC-AuNPs compared to GC-AuNPs, with thrombi visualized as high density on microCT (mCT). mCT imaging using fib-GC-AuNP allowed the prompt detection and quantification of cerebral thrombi, and monitoring of tPA-mediated thrombolytic effect, which reflected histological stroke outcome. Furthermore, recurrent thrombosis could be diagnosed by mCT without further nanoparticle administration for up to 3 weeks. fib-GC-AuNP-based direct cerebral thrombus imaging greatly enhance the value and information obtainable by regular CT, has multiple uses in basic / translational vascular research, and will likely allow personalized thrombolytic therapy in clinic by a) optimizing tPA-dosing to match thrombus burden, b) enabling the rational triage of patients to more radical therapies such as endovascular clot-retrieval, and c) potentially serving as a theranostic platform for targeted delivery of concurrent thrombolysis.

Original languageEnglish
Pages (from-to)1098-1114
Number of pages17
JournalTheranostics
Volume5
Issue number10
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Fibrin
X-Ray Microtomography
Gold
Nanoparticles
Thrombolytic Therapy
Thrombosis
Tissue Plasminogen Activator
Tomography
Intracranial Thrombosis
Stroke
Carotid Artery Thrombosis
Translational Medical Research
Triage
Blood Vessels
Decision Making
Peptides
Therapeutics

Keywords

  • Cerebral infarction
  • Computed tomography
  • Direct thrombus imaging
  • Gold nanoparticles
  • Molecular imaging

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Kim, J. Y., Ryu, J. H., Schellingerhout, D., Sun, I. C., Lee, S. K., Jeon, S., ... Kim, D. E. (2015). Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles. Theranostics, 5(10), 1098-1114. https://doi.org/10.7150/thno.11679

Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles. / Kim, Jeong Yeon; Ryu, Ju Hee; Schellingerhout, Dawid; Sun, In Cheol; Lee, Su Kyoung; Jeon, Sangmin; Kim, Jiwon; Kwon, Ick Chan; Nahrendorf, Matthias; Ahn, Cheol Hee; Kim, Kwang Meyung; Kim, Dong Eog.

In: Theranostics, Vol. 5, No. 10, 2015, p. 1098-1114.

Research output: Contribution to journalArticle

Kim, JY, Ryu, JH, Schellingerhout, D, Sun, IC, Lee, SK, Jeon, S, Kim, J, Kwon, IC, Nahrendorf, M, Ahn, CH, Kim, KM & Kim, DE 2015, 'Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles', Theranostics, vol. 5, no. 10, pp. 1098-1114. https://doi.org/10.7150/thno.11679
Kim, Jeong Yeon ; Ryu, Ju Hee ; Schellingerhout, Dawid ; Sun, In Cheol ; Lee, Su Kyoung ; Jeon, Sangmin ; Kim, Jiwon ; Kwon, Ick Chan ; Nahrendorf, Matthias ; Ahn, Cheol Hee ; Kim, Kwang Meyung ; Kim, Dong Eog. / Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles. In: Theranostics. 2015 ; Vol. 5, No. 10. pp. 1098-1114.
@article{77a354b098bb4886a2f931f994ffa3d5,
title = "Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles",
abstract = "Computed tomography (CT) is the current standard for time-critical decision-making in stroke patients, informing decisions on thrombolytic therapy with tissue plasminogen activator (tPA), which has a narrow therapeutic index. We aimed to develop a CT-based method to directly visualize cerebrovascular thrombi and guide thrombolytic therapy. Glycol-chitosan-coated gold nanoparticles (GC-AuNPs) were synthesized and conjugated to fibrin-targeting peptides, forming fib-GC-AuNP. This targeted imaging agent and non-targeted control agent were characterized in vitro and in vivo in C57Bl/6 mice (n = 107) with FeCl3-induced carotid thrombosis and/or embolic ischemic stroke. Fibrin-binding capacity was superior with fib-GC-AuNPs compared to GC-AuNPs, with thrombi visualized as high density on microCT (mCT). mCT imaging using fib-GC-AuNP allowed the prompt detection and quantification of cerebral thrombi, and monitoring of tPA-mediated thrombolytic effect, which reflected histological stroke outcome. Furthermore, recurrent thrombosis could be diagnosed by mCT without further nanoparticle administration for up to 3 weeks. fib-GC-AuNP-based direct cerebral thrombus imaging greatly enhance the value and information obtainable by regular CT, has multiple uses in basic / translational vascular research, and will likely allow personalized thrombolytic therapy in clinic by a) optimizing tPA-dosing to match thrombus burden, b) enabling the rational triage of patients to more radical therapies such as endovascular clot-retrieval, and c) potentially serving as a theranostic platform for targeted delivery of concurrent thrombolysis.",
keywords = "Cerebral infarction, Computed tomography, Direct thrombus imaging, Gold nanoparticles, Molecular imaging",
author = "Kim, {Jeong Yeon} and Ryu, {Ju Hee} and Dawid Schellingerhout and Sun, {In Cheol} and Lee, {Su Kyoung} and Sangmin Jeon and Jiwon Kim and Kwon, {Ick Chan} and Matthias Nahrendorf and Ahn, {Cheol Hee} and Kim, {Kwang Meyung} and Kim, {Dong Eog}",
year = "2015",
doi = "10.7150/thno.11679",
language = "English",
volume = "5",
pages = "1098--1114",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "10",

}

TY - JOUR

T1 - Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles

AU - Kim, Jeong Yeon

AU - Ryu, Ju Hee

AU - Schellingerhout, Dawid

AU - Sun, In Cheol

AU - Lee, Su Kyoung

AU - Jeon, Sangmin

AU - Kim, Jiwon

AU - Kwon, Ick Chan

AU - Nahrendorf, Matthias

AU - Ahn, Cheol Hee

AU - Kim, Kwang Meyung

AU - Kim, Dong Eog

PY - 2015

Y1 - 2015

N2 - Computed tomography (CT) is the current standard for time-critical decision-making in stroke patients, informing decisions on thrombolytic therapy with tissue plasminogen activator (tPA), which has a narrow therapeutic index. We aimed to develop a CT-based method to directly visualize cerebrovascular thrombi and guide thrombolytic therapy. Glycol-chitosan-coated gold nanoparticles (GC-AuNPs) were synthesized and conjugated to fibrin-targeting peptides, forming fib-GC-AuNP. This targeted imaging agent and non-targeted control agent were characterized in vitro and in vivo in C57Bl/6 mice (n = 107) with FeCl3-induced carotid thrombosis and/or embolic ischemic stroke. Fibrin-binding capacity was superior with fib-GC-AuNPs compared to GC-AuNPs, with thrombi visualized as high density on microCT (mCT). mCT imaging using fib-GC-AuNP allowed the prompt detection and quantification of cerebral thrombi, and monitoring of tPA-mediated thrombolytic effect, which reflected histological stroke outcome. Furthermore, recurrent thrombosis could be diagnosed by mCT without further nanoparticle administration for up to 3 weeks. fib-GC-AuNP-based direct cerebral thrombus imaging greatly enhance the value and information obtainable by regular CT, has multiple uses in basic / translational vascular research, and will likely allow personalized thrombolytic therapy in clinic by a) optimizing tPA-dosing to match thrombus burden, b) enabling the rational triage of patients to more radical therapies such as endovascular clot-retrieval, and c) potentially serving as a theranostic platform for targeted delivery of concurrent thrombolysis.

AB - Computed tomography (CT) is the current standard for time-critical decision-making in stroke patients, informing decisions on thrombolytic therapy with tissue plasminogen activator (tPA), which has a narrow therapeutic index. We aimed to develop a CT-based method to directly visualize cerebrovascular thrombi and guide thrombolytic therapy. Glycol-chitosan-coated gold nanoparticles (GC-AuNPs) were synthesized and conjugated to fibrin-targeting peptides, forming fib-GC-AuNP. This targeted imaging agent and non-targeted control agent were characterized in vitro and in vivo in C57Bl/6 mice (n = 107) with FeCl3-induced carotid thrombosis and/or embolic ischemic stroke. Fibrin-binding capacity was superior with fib-GC-AuNPs compared to GC-AuNPs, with thrombi visualized as high density on microCT (mCT). mCT imaging using fib-GC-AuNP allowed the prompt detection and quantification of cerebral thrombi, and monitoring of tPA-mediated thrombolytic effect, which reflected histological stroke outcome. Furthermore, recurrent thrombosis could be diagnosed by mCT without further nanoparticle administration for up to 3 weeks. fib-GC-AuNP-based direct cerebral thrombus imaging greatly enhance the value and information obtainable by regular CT, has multiple uses in basic / translational vascular research, and will likely allow personalized thrombolytic therapy in clinic by a) optimizing tPA-dosing to match thrombus burden, b) enabling the rational triage of patients to more radical therapies such as endovascular clot-retrieval, and c) potentially serving as a theranostic platform for targeted delivery of concurrent thrombolysis.

KW - Cerebral infarction

KW - Computed tomography

KW - Direct thrombus imaging

KW - Gold nanoparticles

KW - Molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=84945949477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945949477&partnerID=8YFLogxK

U2 - 10.7150/thno.11679

DO - 10.7150/thno.11679

M3 - Article

VL - 5

SP - 1098

EP - 1114

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 10

ER -